
Afzeta 30mg Tablet
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Afatinib dimaleate (30mg)
Overview Afzeta 30mg Tablet
Erbitux 30mg tablets are indicated for treating non-small cell lung cancer in adults with specific epidermal growth factor receptor (EGFR) gene mutations. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician, based on your condition and may be adjusted. Strict adherence to your doctor's prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse reactions. While therapeutic effects may take weeks or months to manifest, discontinue use only upon your doctor's instruction. Common side effects include nausea, skin rash, dryness, and diarrhea; the latter can be severe, requiring prompt medical attention and/or hydration. Regular blood tests may be recommended. Photosensitivity is possible; use sunscreen and protective clothing when exposed to sunlight. Report any eye irritation (pain, redness, dryness) to your doctor. Prior to commencing treatment, disclose any respiratory, liver, or kidney conditions, and all current medications, particularly those for infections. Significant drug interactions are possible; inform your healthcare provider of all medications. This medication is contraindicated during pregnancy and breastfeeding; women of childbearing age must utilize effective contraception.
Primary Ingredients of Afzeta 30mg Tablet
No text provided to rephrase.
Uses of Afzeta 30mg Tablet
Lung cancer (excluding small cell types)
Major Benefits of Afzeta 30mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Afzeta 30mg tablets should be taken on an empty stomach.
Common Side effects of Afzeta 30mg Tablet:
- Diarrhea
- Rash
- Dry skin
- Nausea
- Vomiting
- Loss of appetite
- Itching
- Stomatitis (Inflammation of the mouth)
- Nail disorder
How to use Afzeta 30mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. The Afzeta 30mg Tablet should be taken on an empty stomach.
How Afzeta 30mg Tablet works:
Oncaspar 30mg tablets are an anti-neoplastic agent. Their mechanism involves targeted inhibition of enzyme receptors (EGFR, HER2, and HER4), crucial for cancer cell proliferation. This action suppresses downstream signaling cascades, effectively hindering or reducing cancerous growth.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Afzeta 30mg Tablet and alcohol.
PregnancyCONSULT YOUR DOCTOR
Using Afzeta 30mg tablets during pregnancy poses a confirmed risk to the fetus. Prescribing may occur in exceptional, life-threatening circumstances where the potential benefits outweigh the known dangers. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Afzeta 30mg tablets while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Afzeta 30mg Tablets is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Afzeta 30mg tablets in patients with kidney disease is likely safe. Preliminary findings indicate dose modification may not be necessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Afzeta 30mg Tablet in individuals with liver impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Afzeta 30mg Tablet :
Omit any missed Afzeta 30mg Tablet dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Afzeta 30mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline-Butenamide Hybrid |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Active Class | Kinase inhibitors targeting tyrosine |
